The Alpha 2 MPO ePlus™ bone conduction hearing device brings abutment-free bone conduction to your patients with the smallest implant on the market.
The internal magnet is implanted with a simple surgery that provides a secure and stable implant. The implant lies completely under the skin and has low risk of skin issues.3,4 After healing, the skin and hair look normal, with no titanium abutment protruding through the skin like other bone conduction systems.
The implant consists of two magnets hermetically sealed in a titanium case. An Attract™ adjustable-strength magnetic spacer (connected to the processor) is held in position by the titanium encased magnetic implant. The Alpha 2 MPO ePlus™ sound processor transmits audio vibrations through the skin into the bone where sound is sensed by the cochlea. The Alpha 2 MPO ePlus™ bone-anchored hearing system delivers more gain than any other magnetic transcutaneous system.1,2
Bone conduction hearing therapy with the Alpha 2 MPO ePlus™ is indicated for patients five years and older. Pediatric patients (≤5 years old) and those not wanting to undergo surgery can still experience improved hearing by wearing the Alpha 2 MPO ePlus™ sound processor on a softband or headband.
Get started by identifying patients who are good candidates for bone conduction hearing therapy.
Siegert R. Semi-implantable transcutaneous bone conduction hearing device with fitting on the day of surgery. Presented at the 29th Politzer Society Meeting Antalya, Turkey, Nov 2013.
Centric A and Chennupati, SK, Abutment-free bone-anchored hearing devices in children: Initial results and experience – International Journal of Pediatric Otolaryngology 2014.
Comparing published transcutaneous device specifications of acousto-mechanical gain at 1.6 KHz and 60 dB SPL. Cochlear Baha® Datasheet, BUN203 ISS2 DEC13, Sophono™ Alpha 2 MPO™ Product Specification, S0596-00 Rev C, Sophono™ Test Report: Acousto-Mechanical Gain Alpha2 MPO.
Kohan, D., M.D., Implantable Auditory Devices. Presented at the Ultimate Colorado Midwinter Meeting; Vail, CO; Feb. 3, 2015.